Suchergebnisse - "Cahn, Avivit"

PubPharm (24)

1

Cardio-renal-metabolic disease in primary care setting

enthalten in: Diabetes/metabolism research and reviews | 2024

von Ibrahim, M. | Ba-Essa, E. | Baker, J. | +20

2

SGLT2 Inhibitors and Safety in Older Patients

enthalten in: Heart failure clinics | 2022

von Pollack, R. | Cahn, A.

3

Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents : Post hoc analyses from DECLARE-TIMI 58

enthalten in: Diabetes, obesity & metabolism | 2021

von Cahn, A. | Wiviott, S. | Mosenzon, O. | +15

4

Hypoglycaemia and its management in primary care setting

enthalten in: Diabetes/metabolism research and reviews | 2020

von Ibrahim, M. | Baker, J. | Cahn, A. | +15

5

Safety of dapagliflozin in a broad population of patients with type 2 diabetes : Analyses from the DECLARE-TIMI 58 study

enthalten in: Diabetes, obesity & metabolism | 2020

von Cahn, A. | Raz, I. | Bonaca, M. | +16

6

Efficacy and Safety of Dapagliflozin in the Elderly : Analysis From the DECLARE-TIMI 58 Study

enthalten in: Diabetes care | 2020

von Cahn, A. | Mosenzon, O. | Wiviott, S. | +14

7

SGLT2 inhibitors for primary prevention of cardiovascular events

enthalten in: Journal of diabetes | 2020

von Raz, I. | Cernea, S. | Cahn, A.

8

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction : Observations From the SAVOR-TIMI 53 Trial

enthalten in: Circulation | 2019

von Bergmark, B. | Bhatt, D. | McGuire, D. | +10

CommentIn: Circulation. 2020 Jan 28;141(4):e55-e56. - PMID 31986096

9

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

enthalten in: Circulation | 2019

von Zelniker, T. | Wiviott, S. | Raz, I. | +12

CommentIn: Kidney Int. 2019 Jul;96(1):8-10. - PMID 31229049

10

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial

enthalten in: American heart journal | 2018

von Wiviott, S. | Raz, I. | Bonaca, M. | +13